Product Description

Spnib 70mg Tablet is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies.  

Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. The abnormality in this chromosome causes fusion of BCR and ABL gene that codes for proteins with tyrosine kinase activity, which, in turn, influences cell multiplication, division and survival.

Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long.

 

Uses of Spnib 70mg Tablet:

• Treatment for children and adults with chronic myeloid leukemia.
• Treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

How to use

Use as directed

Uses

Treatment of Blood cancer

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

 

Serious:

• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction

Storage

Store below 30℃